Eckert & Ziegler Strahlen-und Medizintechnik AG announced today that it has submitted a non-binding proposal to the Board of Directors of Theragenics Corporation (TGX), based in Buford, Georgia, USA to acquire all the outstanding shares of Theragenics for $2.20 per share, in cash.
The offer represents a total equity value of approximately $74 million and a premium of 38.4% over Theragenics’ closing stock price on March 16, 2011. The offer also represents a premium of 15.8% over the 52 week high trading price of Theragenics stock.
Shares of Theragenics Corp. are currently higher on the session by 25.79%, trading at $2.00.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply